000			01637 a2200481 4500
005			20250517181527.0
264		0	_c20180615
008			201806s 0 0 eng d
022			_a1878-5905
024	7		_a10.1016/j.biomaterials.2017.10.020 _2doi
040			_aNLM _beng _cNLM
100	1		_aMarturano-Kruik, A
245	0	0	_aBiomechanical regulation of drug sensitivity in an engineered model of human tumor. _h[electronic resource]
260			_bBiomaterials _cJan 2018
300			_a150-161 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Agents _xpharmacology
650	0	4	_aBiomimetic Materials _xmetabolism
650	0	4	_aBioreactors
650	0	4	_aBone Neoplasms _xdrug therapy
650	0	4	_aCell Line, Tumor
650	0	4	_aCore Binding Factor Alpha 1 Subunit _xmetabolism
650	0	4	_aDrug Resistance, Neoplasm _xdrug effects
650	0	4	_aHumans
650	0	4	_aMAP Kinase Signaling System _xdrug effects
650	0	4	_aMechanotransduction, Cellular
650	0	4	_aMice
650	0	4	_aMice, SCID
650	0	4	_aSarcoma, Ewing _xdrug therapy
650	0	4	_aSurvival Analysis
650	0	4	_aTissue Engineering
650	0	4	_aTumor Microenvironment _xdrug effects
650	0	4	_aXenograft Model Antitumor Assays
700	1		_aVillasante, A
700	1		_aYaeger, K
700	1		_aAmbati, S R
700	1		_aChramiec, A
700	1		_aRaimondi, M T
700	1		_aVunjak-Novakovic, G
773	0		_tBiomaterials _gvol. 150 _gp. 150-161
856	4	0	_uhttps://doi.org/10.1016/j.biomaterials.2017.10.020 _zAvailable from publisher's website
999			_c27693465 _d27693465